Health Condition 1: J069- Acute upper respiratory infection,unspecified
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Children whose parents are willing to give consent/assent for clinical trial. Children having cardinal features of respiratory allergy. Children aged between 06 years to 14 years of either sex. Children with a history of three or more episode within the past year.
Exclusion criteria
Exclusion criteria: Children cases of respiratory allergies that are severe and complicated. Children aged below 06 years and above 14 years of either sex. Children suffering from major systemic illness necessitating long-term treatment. Children with evidence of malignancy, genetic or congenital anomaly. Children diagnosed with Tuberculosis, Plural effusion, Emphysema, Lung abscess, Bronchiectasis, Pleurisy, Nasal polyps etc. H/o hypersensitivity to any of the trial drug or their ingredient. .
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| to check the effectiveness and efficacy of the drug and procedure in Respiratory Allergic DisordersTimepoint: 56 days | — |
Secondary
| Measure | Time frame |
|---|---|
| To compare both the drugsTimepoint: 56 days | — |
Countries
India
Contacts
Madan Mohan Malviya Government Ayurved College Udaipur,